Terms: = Kidney tumors AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
5 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Midkine noncanonically suppresses AMPK activation through disrupting the lkb1-STRAD-Mo25 complex.
Xia T; Chen D; Liu X; Qi H; Wang W; Chen H; Ling T; Otkur W; Zhang CS; Kim J; Lin SC; Piao HL
Cell Death Dis; 2022 Apr; 13(4):414. PubMed ID: 35487917
[TBL] [Abstract] [Full Text] [Related]
3. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
Hasanvand A
Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
[TBL] [Abstract] [Full Text] [Related]
4. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
Lin J; Cao Y; Yu L; Lin L
Medicine (Baltimore); 2018 Sep; 97(39):e12336. PubMed ID: 30278510
[TBL] [Abstract] [Full Text] [Related]
5. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the lkb1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract] [Full Text] [Related]
